Curevac names Franz-Werner Haas as CEO

This post was originally published on this site

https://i-invdn-com.akamaized.net/news/indicatornews_6_M_1440048362.jpg

A spokesman for Curevac said Hoerr was continuing to recover and added that there was no final decision yet on his future role at the company, which has filed for an initial public offering in the United States as it races to develop a vaccine for COVID-19.